Rankings
▼
Calendar
XOMAP Q4 2019 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$422,000
-75.0% YoY
Gross Profit
$292,000
69.2% margin
Operating Income
-$4M
-948.1% margin
Net Income
-$4M
-1023.9% margin
EPS (Diluted)
$-0.38
QoQ Revenue Growth
-95.2%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$715,000
Balance Sheet
Total Assets
$96M
Total Liabilities
$52M
Stockholders' Equity
$44M
Cash & Equivalents
$57M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$422,000
$2M
-75.0%
Gross Profit
$292,000
$1M
-79.8%
Operating Income
-$4M
-$3M
-16.9%
Net Income
-$4M
-$3M
-43.5%
← FY 2019
All Quarters
Q1 2020 →